Pancreatic antegrade needle-knife (PANK) for treatment of symptomatic pancreatic duct obstruction in Whipple patients (with video)
Background
Endoscopic decompression of symptomatic main pancreatic duct (MPD) dilation in Whipple patients is often difficult because of stenosis of the pancreaticojejunal (PJ) anastomosis.
Objective
To evaluate the feasibility and procedural safety of the pancreatic antegrade needle-knife (PANK) technique, with the goal of restoring antegrade MPD flow, when endoscopic retrograde pancreatography (ERP) and EUS-guided rendezvous fail.
Setting
Tertiary care center.
Design
Retrospective series.
Patients
Three patients with symptomatic MPD dilation refractory to ERP and EUS-guided rendezvous.
Interventions
Under EUS guidance, a 19-gauge echo-needle was used to gain access to the dilated MPD and a Jagwire advanced. After failed attempts at antegrade guidewire passage across the PJ stenosis, deep transgastric MPD access was achieved via a Soehendra stent retriever and balloon dilation. Careful antegrade needle-knife of the stenotic site was performed. A long pancreatic stent spanning the jejunum, MPD, and gastric access site was placed. Four to 8 weeks later, this stent was upsized and converted to a PJ stent, which in turn was removed 4 weeks thereafter.
Main Outcome Measurements
Technical feasibility and complications.
Results
All 3 patients successfully underwent the PANK procedure. Pre- and post-MRCP studies showed the mean MPD diameter decreased 60% from 8.3 mm to 3.6 mm (mean follow-up 8 months). At 24-month follow-up, all 3 patients experienced decreased or resolved pain without further need for MPD intervention.
Limitations
Retrospective study with small numbers.
Conclusions
When ERP and EUS rendezvous fail, the PANK procedure using a staged stent strategy seems to be an effective means of MPD decompression.
Abbreviations: EPG, endoscopic pancreatogastrostomy, ERP, endoscopic retrograde pancreatography, MPD, main pancreatic duct, PANK, pancreatic antegrade needle-knife, PJ, pancreaticojejunal
To access this article, please choose from the options below
DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: Dr. Carr-Locke: consultant to Boston Scientific, Cook Medical, and ERBE USA; royalties from U.S. Endoscopy and Telemed Systems. Dr. Thompson: research support from and consultant to Olympus and Bard; consultant to Boston Scientific; consultant to and stock in Boston Endoscopic Engineering. The other authors disclosed no financial relationships relevant to this publication.
PII: S0016-5107(10)01875-4
doi:10.1016/j.gie.2010.07.017
© 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
